117 related articles for article (PubMed ID: 23414400)
1. The need for a new vaccine against lyme borreliosis.
Barrett PN; Portsmouth D
Expert Rev Vaccines; 2013 Feb; 12(2):101-3. PubMed ID: 23414400
[No Abstract] [Full Text] [Related]
2. A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studies.
Barrett PN; Portsmouth D
Expert Rev Vaccines; 2013 Sep; 12(9):973-5. PubMed ID: 24053389
[No Abstract] [Full Text] [Related]
3. Lyme vaccine demonized by advocacy groups.
McSweegan E
Nature; 2006 Mar; 440(7082):278. PubMed ID: 16541048
[No Abstract] [Full Text] [Related]
4. Safety, immunogenicity, and efficacy of Borrelia burgdorferi outer surface protein A (OspA) vaccine: A meta-analysis.
Zhao H; Bao FF; Liu A
J Infect Dev Ctries; 2017 Jan; 11(1):1-9. PubMed ID: 28141584
[TBL] [Abstract][Full Text] [Related]
5. A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
Wressnigg N; Barrett PN; Pöllabauer EM; O'Rourke M; Portsmouth D; Schwendinger MG; Crowe BA; Livey I; Dvorak T; Schmitt B; Zeitlinger M; Kollaritsch H; Esen M; Kremsner PG; Jelinek T; Aschoff R; Weisser R; Naudts IF; Aichinger G
Clin Vaccine Immunol; 2014 Nov; 21(11):1490-9. PubMed ID: 25185574
[TBL] [Abstract][Full Text] [Related]
6. Availability of Lyme disease vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(2):35-6, 43. PubMed ID: 9933128
[TBL] [Abstract][Full Text] [Related]
7. Lyme disease vaccination: safety first.
Stricker RB; Johnson L
Lancet Infect Dis; 2014 Jan; 14(1):12. PubMed ID: 24355028
[No Abstract] [Full Text] [Related]
8. Lyme disease vaccination: are we ready to try again?
Lantos PM
Lancet Infect Dis; 2013 Aug; 13(8):643-4. PubMed ID: 23665340
[No Abstract] [Full Text] [Related]
9. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial.
Sikand VK; Halsey N; Krause PJ; Sood SK; Geller R; Van Hoecke C; Buscarino C; Parenti D;
Pediatrics; 2001 Jul; 108(1):123-8. PubMed ID: 11433064
[TBL] [Abstract][Full Text] [Related]
10. Characterization and optimization of a novel vaccine for protection against Lyme borreliosis.
Comstedt P; Hanner M; Schüler W; Meinke A; Schlegl R; Lundberg U
Vaccine; 2015 Nov; 33(44):5982-8. PubMed ID: 26277070
[TBL] [Abstract][Full Text] [Related]
11. Lyme disease vaccination: safety first - authors' reply.
Barrett PN; Crowe BA; Wressnigg N; Portsmouth D; Aichinger G
Lancet Infect Dis; 2014 Jan; 14(1):12-13. PubMed ID: 24355029
[No Abstract] [Full Text] [Related]
12. Neurological complications of vaccination with outer surface protein A (OspA).
Marks DH
Int J Risk Saf Med; 2011; 23(2):89-96. PubMed ID: 21673416
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.
Wressnigg N; Pöllabauer EM; Aichinger G; Portsmouth D; Löw-Baselli A; Fritsch S; Livey I; Crowe BA; Schwendinger M; Brühl P; Pilz A; Dvorak T; Singer J; Firth C; Luft B; Schmitt B; Zeitlinger M; Müller M; Kollaritsch H; Paulke-Korinek M; Esen M; Kremsner PG; Ehrlich HJ; Barrett PN
Lancet Infect Dis; 2013 Aug; 13(8):680-9. PubMed ID: 23665341
[TBL] [Abstract][Full Text] [Related]
14. Lyme disease vaccination: safety first - author's reply.
Lantos PM
Lancet Infect Dis; 2014 Jan; 14(1):13. PubMed ID: 24355030
[No Abstract] [Full Text] [Related]
15. [Lyme borreliosis--vaccines in the "pipeline"].
Kramer M
MMW Fortschr Med; 1999 Jun; 141(25):52-3. PubMed ID: 10897909
[No Abstract] [Full Text] [Related]
16. Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1999 Jun; 48(RR-7):1-17, 21-5. PubMed ID: 10371254
[TBL] [Abstract][Full Text] [Related]
17. Need for a New Lyme Disease Vaccine.
Plotkin SA
N Engl J Med; 2016 Sep; 375(10):911-3. PubMed ID: 27602662
[No Abstract] [Full Text] [Related]
18. Who should receive the Lyme disease vaccine?
Taege AJ
Cleve Clin J Med; 2000 Apr; 67(4):239-40. PubMed ID: 10780094
[No Abstract] [Full Text] [Related]
19. Arthritis following recombinant outer surface protein A vaccination for Lyme disease.
Rosé CD; Fawcett PT; Gibney KM
J Rheumatol; 2001 Nov; 28(11):2555-7. PubMed ID: 11708435
[TBL] [Abstract][Full Text] [Related]
20. Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment.
Nayak A; Schüler W; Seidel S; Gomez I; Meinke A; Comstedt P; Lundberg U
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
